Double Voiding for Overactive Bladder
Links shared publicly online about this topic
UC HealthNews : UC HEALTH LINE: Bladder 'Pacemaker' Can Fix Overactive Bladder, Other Voiding Issues
healthnews.uc.edu — “If your day is punctuated by urgent trips to the bathroom or trouble emptying your bladder, you might have a voiding dysfunction condition. The good news is that it can be easily treated.” View full resource at healthnews.uc.edu
Most Recently Shared on April 28, 2011 at 5:15 pm By:
A new "pacemaker" for your #bladder might be the solution to your "gotta go right now" days. Learn more: http://bit.ly/mpT3Ea
Urology Article | Urinary Bladder, Overactive
mdlinx.com — “Initial combined treatment with anticholinergics and alpha-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study” View full resource at mdlinx.com
Most Recently Shared on August 13, 2011 at 1:42 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Initial combined treatment with anticholinergics and alpha-blockers for men with lower urinary tract sy... http://t.co/vJm7tCC #urology
Clinical Trial: Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding” View full resource at renalandurologynews.com
Most Recently Shared on July 26, 2010 at 8:40 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Clinical Trial: Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndr... http://bit.ly/asIX6s
Allergan Seeks Approval for Botox in the Treatment of Overactive Bladder - ABC News
abcnews.go.com — “Allergan Seeks Approval for Botox in the Treatment of Overactive Bladder - ABC News” View full resource at abcnews.go.com
Most Recently Shared on August 5, 2011 at 4:09 pm By:
Drugs and Devices OW OW Health
Botox for Bladders? 11 Double-Duty Drugs: TK http://abcn.ws/prtEj6
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) - ONA
oncologynurseadvisor.com — “Antares Pharma announced that it has completed enrollment in the double-blind portion of their Phase 3 trial of Anturol (transdermal oxybutynin ATD gel) for the treatment of overactive bladder (OAB).” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 2, 2010 at 3:58 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) http://goo.gl/fb/FPaY
Phase 3 study of Anturol for the treatment of overactive bladder (OAB) - MPR
empr.com — “Antares Pharma announced that it has completed enrollment in the double-blind portion of their Phase 3 trial of Anturol (transdermal oxybutynin ATD gel) for the treatment of overactive bladder (OAB).” View full resource at empr.com
Most Recently Shared on March 2, 2010 at 4:03 pm By:
MPR News: Phase 3 study of Anturol for the treatment of overactive bladder (OAB): Antares Pharma announced that it... http://bit.ly/bmHRqt
Antares Pharma Announces Completion Of Patient Enrollment In Phase 3 Pivotal Trial Of Anturol™ For The Treatment Of Overactive Bladder
medicalnewstoday.com — “Antares Pharma, Inc. (NYSE Amex: AIS) announced that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin A” View full resource at medicalnewstoday.com
Most Recently Shared on March 4, 2010 at 4:12 pm By:
MNT Clinical Trials Health News
Antares Pharma Announces Completion Of Patient Enrollment In Phase 3 Pivotal Trial Of Anturol™ For The Treatment... http://mnt.to/3ysd
Increase in Urinary Voiding Dysfunctions Predicted Globally
drjkm.com — “Urinary Voiding abnormalities such as overactive bladder and incontinence are expected to increase over the next 10 years. Read more about at www.drjkm.com” View full resource at drjkm.com
Most Recently Shared on October 3, 2011 at 7:47 pm By:
Kyle Mathews Veterinarian, Physician, Doctor, ObGyn Physician, and Surgeon
Increase in Urinary Voiding Dysfunctions Predicted Globally http://t.co/paYFx6XK
Study suggests hereditary link for bladder disorders - Related Stories - AAP SmartBrief
smartbrief.com — “Researchers said mothers of children with overactive bladder or dysfunctional voiding were more likely to report having similar symptoms as a child. Experts said more research is needed on the possible genetics involved in overactive bladder and dysfunctional voiding. <a href='/servlet/aaRedirect?ur” View full resource at smartbrief.com
Most Recently Shared on April 9, 2010 at 5:29 am By:
Clara Song Doctor, Pediatrician, and Physician
Study suggests hereditary link for bladder disorders http://sbne.ws/r/4p2g
Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB
news-medical.net — “Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.” View full resource at news-medical.net
Most Recently Shared on April 5, 2011 at 12:48 pm By:
Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB: Uroplasty,... http://bit.ly/fme98w
Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB
news-medical.net — “Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that two private insurance payers have elected to cover posterior tibial nerve stimulation (PTNS) using its Urgent PC Neuromodulation System for the treatment of overactive bladder (OAB) and associated symptoms.” View full resource at news-medical.net
Most Recently Shared on April 6, 2011 at 3:24 am By:
Urology & Nephrology OW Health
Insurance payers extend coverage for PTNS using Uroplasty's Urgent PC Neuromodulation System for OAB: Uroplasty,... http://bit.ly/elCJRe
Botulinum toxin offers minimally invasive Tx for idiopathic OAB - - ModernMedicine
modernmedicine.com — “Botulinum toxin A (Botox, Dysport) appears to be beneficial for the treatment of patients with idiopathic overactive bladder that is not adequately managed by anticholinergic drug therapy, according to a double-blind, placebo-controlled study presented at the European Association of Urology annual congress in Barcelona, Spain.” View full resource at modernmedicine.com
Most Recently Shared on May 1, 2010 at 4:11 pm By:
Botulinum toxin offers minimally invasive Tx for idiopathic OAB - http://dld.bz/bH2M
Coverage Initiated By Two Regional Medicare Carriers For Posterior Tibial Nerve Stimulation (PTNS) - QualityPoint Technologies
qualitypointtech.net — “Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced that Noridian Administrative Services, LLC and Palmetto GBA, South Carolina, both regional Medicare carriers, now cover percutaneous, posterior tibial nerve stimulation (PTNS) using the Urgent PC Neuromodulation System for the treatment of the symptoms of overactive bladder. Noridian administers benefits for Medicare beneficiarie” View full resource at qualitypointtech.net
Most Recently Shared on August 24, 2010 at 1:06 pm By:
Coverage Initiated By Two Regional Medicare Carriers For Posterior Tibial Nerve Stimulation (PTNS): Uroplasty, Inc... http://bit.ly/du4d2C
Coverage Initiated By Two Regional Medicare Carriers For Posterior Tibial Nerve Stimulation (PTNS)
medicalnewstoday.com — “Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced that Noridian Administrati” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2010 at 2:00 pm By:
Coverage Initiated By Two Regional Medicare Carriers For Posterior Tibial Nerve Stimulation (PTNS) http://mnt.to/3HLt #urology
New Study Of Percutaneous Tibial Nerve Stimulation Vs. Placebo Reinforces Evidence Of Effectiveness
medicalnewstoday.com — “Uroplasty, Inc. (Nasdaq: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, highlighted results of a study Perc” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 7:05 pm By:
New Study Of Percutaneous Tibial Nerve Stimulation Vs. Placebo Reinforces Evidence Of Effectiveness http://mnt.to/3KhH #urology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
UC Health
The UC Academic Health Center is known nationally for training health care professionals and providing leading-edge research and patient care.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
Advertisement
